nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—HTR2C—type 2 diabetes mellitus	0.221	0.667	CbGaD
Escitalopram—CYP3A4—type 2 diabetes mellitus	0.111	0.333	CbGaD
Escitalopram—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0402	0.104	CbGbCtD
Escitalopram—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0347	0.09	CbGbCtD
Escitalopram—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0271	0.0703	CbGbCtD
Escitalopram—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0231	0.0598	CbGbCtD
Escitalopram—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0231	0.0598	CbGbCtD
Escitalopram—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0213	0.0552	CbGbCtD
Escitalopram—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0206	0.0533	CbGbCtD
Escitalopram—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0175	0.0454	CbGbCtD
Escitalopram—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0173	0.0448	CbGbCtD
Escitalopram—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0162	0.0419	CbGbCtD
Escitalopram—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0154	0.04	CbGbCtD
Escitalopram—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0141	0.0366	CbGbCtD
Escitalopram—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0133	0.0344	CbGbCtD
Escitalopram—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0127	0.033	CbGbCtD
Escitalopram—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0123	0.032	CbGbCtD
Escitalopram—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0118	0.0306	CbGbCtD
Escitalopram—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0112	0.0289	CbGbCtD
Escitalopram—CYP2C19—Losartan—type 2 diabetes mellitus	0.0108	0.028	CbGbCtD
Escitalopram—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00845	0.0219	CbGbCtD
Escitalopram—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0081	0.021	CbGbCtD
Escitalopram—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0081	0.021	CbGbCtD
Escitalopram—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00766	0.0199	CbGbCtD
Escitalopram—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00571	0.0148	CbGbCtD
Escitalopram—CYP3A4—Losartan—type 2 diabetes mellitus	0.00522	0.0135	CbGbCtD
Escitalopram—Citalopram—HTR2C—type 2 diabetes mellitus	0.00129	0.328	CrCbGaD
Escitalopram—Citalopram—CYP2E1—type 2 diabetes mellitus	0.00102	0.26	CrCbGaD
Escitalopram—Citalopram—CYP1A2—type 2 diabetes mellitus	0.000975	0.248	CrCbGaD
Escitalopram—Citalopram—CYP3A4—type 2 diabetes mellitus	0.000645	0.164	CrCbGaD
Escitalopram—Dyspnoea—Valsartan—type 2 diabetes mellitus	3.79e-05	0.000182	CcSEcCtD
Escitalopram—Vertigo—Losartan—type 2 diabetes mellitus	3.78e-05	0.000181	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000181	CcSEcCtD
Escitalopram—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.78e-05	0.000181	CcSEcCtD
Escitalopram—Somnolence—Valsartan—type 2 diabetes mellitus	3.78e-05	0.000181	CcSEcCtD
Escitalopram—Syncope—Losartan—type 2 diabetes mellitus	3.77e-05	0.000181	CcSEcCtD
Escitalopram—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.77e-05	0.000181	CcSEcCtD
Escitalopram—Leukopenia—Losartan—type 2 diabetes mellitus	3.77e-05	0.000181	CcSEcCtD
Escitalopram—Discomfort—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.00018	CcSEcCtD
Escitalopram—Skin disorder—Metformin—type 2 diabetes mellitus	3.76e-05	0.00018	CcSEcCtD
Escitalopram—Immune system disorder—Ramipril—type 2 diabetes mellitus	3.74e-05	0.00018	CcSEcCtD
Escitalopram—Hyperhidrosis—Metformin—type 2 diabetes mellitus	3.74e-05	0.000179	CcSEcCtD
Escitalopram—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.74e-05	0.000179	CcSEcCtD
Escitalopram—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000179	CcSEcCtD
Escitalopram—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.72e-05	0.000179	CcSEcCtD
Escitalopram—Dry mouth—Irbesartan—type 2 diabetes mellitus	3.72e-05	0.000179	CcSEcCtD
Escitalopram—Palpitations—Losartan—type 2 diabetes mellitus	3.72e-05	0.000178	CcSEcCtD
Escitalopram—Nausea—Glimepiride—type 2 diabetes mellitus	3.71e-05	0.000178	CcSEcCtD
Escitalopram—Arrhythmia—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000178	CcSEcCtD
Escitalopram—Loss of consciousness—Losartan—type 2 diabetes mellitus	3.7e-05	0.000177	CcSEcCtD
Escitalopram—Nausea—Sitagliptin—type 2 diabetes mellitus	3.7e-05	0.000177	CcSEcCtD
Escitalopram—Dyspepsia—Orlistat—type 2 diabetes mellitus	3.69e-05	0.000177	CcSEcCtD
Escitalopram—Asthenia—Glyburide—type 2 diabetes mellitus	3.69e-05	0.000177	CcSEcCtD
Escitalopram—Decreased appetite—Valsartan—type 2 diabetes mellitus	3.69e-05	0.000177	CcSEcCtD
Escitalopram—Anorexia—Metformin—type 2 diabetes mellitus	3.69e-05	0.000177	CcSEcCtD
Escitalopram—Cough—Losartan—type 2 diabetes mellitus	3.67e-05	0.000176	CcSEcCtD
Escitalopram—Urticaria—Gliclazide—type 2 diabetes mellitus	3.67e-05	0.000176	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	3.67e-05	0.000176	CcSEcCtD
Escitalopram—Alopecia—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000176	CcSEcCtD
Escitalopram—Fatigue—Valsartan—type 2 diabetes mellitus	3.66e-05	0.000176	CcSEcCtD
Escitalopram—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.65e-05	0.000175	CcSEcCtD
Escitalopram—Abdominal pain—Gliclazide—type 2 diabetes mellitus	3.65e-05	0.000175	CcSEcCtD
Escitalopram—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	3.65e-05	0.000175	CcSEcCtD
Escitalopram—Oedema—Irbesartan—type 2 diabetes mellitus	3.65e-05	0.000175	CcSEcCtD
Escitalopram—Decreased appetite—Orlistat—type 2 diabetes mellitus	3.65e-05	0.000175	CcSEcCtD
Escitalopram—Pruritus—Glyburide—type 2 diabetes mellitus	3.64e-05	0.000175	CcSEcCtD
Escitalopram—Mental disorder—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000174	CcSEcCtD
Escitalopram—Constipation—Valsartan—type 2 diabetes mellitus	3.63e-05	0.000174	CcSEcCtD
Escitalopram—Infection—Irbesartan—type 2 diabetes mellitus	3.63e-05	0.000174	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.62e-05	0.000174	CcSEcCtD
Escitalopram—Fatigue—Orlistat—type 2 diabetes mellitus	3.62e-05	0.000174	CcSEcCtD
Escitalopram—Hypotension—Metformin—type 2 diabetes mellitus	3.61e-05	0.000173	CcSEcCtD
Escitalopram—Erythema—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000173	CcSEcCtD
Escitalopram—Malnutrition—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000173	CcSEcCtD
Escitalopram—Shock—Irbesartan—type 2 diabetes mellitus	3.59e-05	0.000172	CcSEcCtD
Escitalopram—Pain—Orlistat—type 2 diabetes mellitus	3.59e-05	0.000172	CcSEcCtD
Escitalopram—Chest pain—Losartan—type 2 diabetes mellitus	3.58e-05	0.000172	CcSEcCtD
Escitalopram—Myalgia—Losartan—type 2 diabetes mellitus	3.58e-05	0.000172	CcSEcCtD
Escitalopram—Arthralgia—Losartan—type 2 diabetes mellitus	3.58e-05	0.000172	CcSEcCtD
Escitalopram—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.58e-05	0.000172	CcSEcCtD
Escitalopram—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	3.58e-05	0.000172	CcSEcCtD
Escitalopram—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.57e-05	0.000171	CcSEcCtD
Escitalopram—Anxiety—Losartan—type 2 diabetes mellitus	3.57e-05	0.000171	CcSEcCtD
Escitalopram—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.56e-05	0.000171	CcSEcCtD
Escitalopram—Rash—Bromocriptine—type 2 diabetes mellitus	3.55e-05	0.00017	CcSEcCtD
Escitalopram—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.55e-05	0.00017	CcSEcCtD
Escitalopram—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.54e-05	0.00017	CcSEcCtD
Escitalopram—Tension—Ramipril—type 2 diabetes mellitus	3.54e-05	0.00017	CcSEcCtD
Escitalopram—Discomfort—Losartan—type 2 diabetes mellitus	3.54e-05	0.00017	CcSEcCtD
Escitalopram—Dysgeusia—Ramipril—type 2 diabetes mellitus	3.53e-05	0.00017	CcSEcCtD
Escitalopram—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.000169	CcSEcCtD
Escitalopram—Headache—Bromocriptine—type 2 diabetes mellitus	3.53e-05	0.000169	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.52e-05	0.000169	CcSEcCtD
Escitalopram—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.52e-05	0.000169	CcSEcCtD
Escitalopram—Nervousness—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000168	CcSEcCtD
Escitalopram—Dry mouth—Losartan—type 2 diabetes mellitus	3.5e-05	0.000168	CcSEcCtD
Escitalopram—Anorexia—Irbesartan—type 2 diabetes mellitus	3.48e-05	0.000167	CcSEcCtD
Escitalopram—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.47e-05	0.000167	CcSEcCtD
Escitalopram—Paraesthesia—Metformin—type 2 diabetes mellitus	3.47e-05	0.000167	CcSEcCtD
Escitalopram—Muscle spasms—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000166	CcSEcCtD
Escitalopram—Confusional state—Losartan—type 2 diabetes mellitus	3.46e-05	0.000166	CcSEcCtD
Escitalopram—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.46e-05	0.000166	CcSEcCtD
Escitalopram—Dyspnoea—Metformin—type 2 diabetes mellitus	3.45e-05	0.000165	CcSEcCtD
Escitalopram—Somnolence—Metformin—type 2 diabetes mellitus	3.44e-05	0.000165	CcSEcCtD
Escitalopram—Oedema—Losartan—type 2 diabetes mellitus	3.43e-05	0.000165	CcSEcCtD
Escitalopram—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3.43e-05	0.000165	CcSEcCtD
Escitalopram—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.43e-05	0.000165	CcSEcCtD
Escitalopram—Infection—Losartan—type 2 diabetes mellitus	3.41e-05	0.000164	CcSEcCtD
Escitalopram—Hypotension—Irbesartan—type 2 diabetes mellitus	3.41e-05	0.000164	CcSEcCtD
Escitalopram—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.41e-05	0.000163	CcSEcCtD
Escitalopram—Dyspepsia—Metformin—type 2 diabetes mellitus	3.4e-05	0.000163	CcSEcCtD
Escitalopram—Tremor—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000162	CcSEcCtD
Escitalopram—Shock—Losartan—type 2 diabetes mellitus	3.38e-05	0.000162	CcSEcCtD
Escitalopram—Urticaria—Valsartan—type 2 diabetes mellitus	3.37e-05	0.000162	CcSEcCtD
Escitalopram—Nervous system disorder—Losartan—type 2 diabetes mellitus	3.37e-05	0.000162	CcSEcCtD
Escitalopram—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.36e-05	0.000161	CcSEcCtD
Escitalopram—Decreased appetite—Metformin—type 2 diabetes mellitus	3.36e-05	0.000161	CcSEcCtD
Escitalopram—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.36e-05	0.000161	CcSEcCtD
Escitalopram—Tachycardia—Losartan—type 2 diabetes mellitus	3.35e-05	0.000161	CcSEcCtD
Escitalopram—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000161	CcSEcCtD
Escitalopram—Nausea—Bromocriptine—type 2 diabetes mellitus	3.34e-05	0.00016	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.34e-05	0.00016	CcSEcCtD
Escitalopram—Fatigue—Metformin—type 2 diabetes mellitus	3.33e-05	0.00016	CcSEcCtD
Escitalopram—Urticaria—Orlistat—type 2 diabetes mellitus	3.33e-05	0.00016	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.00016	CcSEcCtD
Escitalopram—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.32e-05	0.000159	CcSEcCtD
Escitalopram—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.32e-05	0.000159	CcSEcCtD
Escitalopram—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.32e-05	0.000159	CcSEcCtD
Escitalopram—Asthenia—Gliclazide—type 2 diabetes mellitus	3.32e-05	0.000159	CcSEcCtD
Escitalopram—Agitation—Ramipril—type 2 diabetes mellitus	3.32e-05	0.000159	CcSEcCtD
Escitalopram—Constipation—Metformin—type 2 diabetes mellitus	3.31e-05	0.000159	CcSEcCtD
Escitalopram—Angioedema—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000158	CcSEcCtD
Escitalopram—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.28e-05	0.000157	CcSEcCtD
Escitalopram—Anorexia—Losartan—type 2 diabetes mellitus	3.27e-05	0.000157	CcSEcCtD
Escitalopram—Vomiting—Glyburide—type 2 diabetes mellitus	3.27e-05	0.000157	CcSEcCtD
Escitalopram—Pruritus—Gliclazide—type 2 diabetes mellitus	3.27e-05	0.000157	CcSEcCtD
Escitalopram—Malaise—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000156	CcSEcCtD
Escitalopram—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000156	CcSEcCtD
Escitalopram—Rash—Glyburide—type 2 diabetes mellitus	3.25e-05	0.000156	CcSEcCtD
Escitalopram—Somnolence—Irbesartan—type 2 diabetes mellitus	3.24e-05	0.000156	CcSEcCtD
Escitalopram—Dermatitis—Glyburide—type 2 diabetes mellitus	3.24e-05	0.000156	CcSEcCtD
Escitalopram—Vertigo—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000156	CcSEcCtD
Escitalopram—Syncope—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000155	CcSEcCtD
Escitalopram—Leukopenia—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000155	CcSEcCtD
Escitalopram—Headache—Glyburide—type 2 diabetes mellitus	3.22e-05	0.000155	CcSEcCtD
Escitalopram—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.21e-05	0.000154	CcSEcCtD
Escitalopram—Hypotension—Losartan—type 2 diabetes mellitus	3.21e-05	0.000154	CcSEcCtD
Escitalopram—Palpitations—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000153	CcSEcCtD
Escitalopram—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.19e-05	0.000153	CcSEcCtD
Escitalopram—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.17e-05	0.000152	CcSEcCtD
Escitalopram—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000152	CcSEcCtD
Escitalopram—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.16e-05	0.000152	CcSEcCtD
Escitalopram—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.16e-05	0.000152	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.15e-05	0.000151	CcSEcCtD
Escitalopram—Cough—Ramipril—type 2 diabetes mellitus	3.15e-05	0.000151	CcSEcCtD
Escitalopram—Fatigue—Irbesartan—type 2 diabetes mellitus	3.15e-05	0.000151	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.13e-05	0.00015	CcSEcCtD
Escitalopram—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.13e-05	0.00015	CcSEcCtD
Escitalopram—Convulsion—Ramipril—type 2 diabetes mellitus	3.13e-05	0.00015	CcSEcCtD
Escitalopram—Pain—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.00015	CcSEcCtD
Escitalopram—Constipation—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.00015	CcSEcCtD
Escitalopram—Insomnia—Losartan—type 2 diabetes mellitus	3.11e-05	0.000149	CcSEcCtD
Escitalopram—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.09e-05	0.000148	CcSEcCtD
Escitalopram—Paraesthesia—Losartan—type 2 diabetes mellitus	3.08e-05	0.000148	CcSEcCtD
Escitalopram—Urticaria—Metformin—type 2 diabetes mellitus	3.07e-05	0.000147	CcSEcCtD
Escitalopram—Myalgia—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000147	CcSEcCtD
Escitalopram—Chest pain—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000147	CcSEcCtD
Escitalopram—Arthralgia—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000147	CcSEcCtD
Escitalopram—Dyspnoea—Losartan—type 2 diabetes mellitus	3.06e-05	0.000147	CcSEcCtD
Escitalopram—Anxiety—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000147	CcSEcCtD
Escitalopram—Nausea—Glyburide—type 2 diabetes mellitus	3.06e-05	0.000147	CcSEcCtD
Escitalopram—Abdominal pain—Metformin—type 2 diabetes mellitus	3.06e-05	0.000147	CcSEcCtD
Escitalopram—Dizziness—Gliclazide—type 2 diabetes mellitus	3.06e-05	0.000147	CcSEcCtD
Escitalopram—Somnolence—Losartan—type 2 diabetes mellitus	3.05e-05	0.000147	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000146	CcSEcCtD
Escitalopram—Asthenia—Valsartan—type 2 diabetes mellitus	3.05e-05	0.000146	CcSEcCtD
Escitalopram—Discomfort—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000146	CcSEcCtD
Escitalopram—Dyspepsia—Losartan—type 2 diabetes mellitus	3.02e-05	0.000145	CcSEcCtD
Escitalopram—Asthenia—Orlistat—type 2 diabetes mellitus	3.01e-05	0.000144	CcSEcCtD
Escitalopram—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.01e-05	0.000144	CcSEcCtD
Escitalopram—Pruritus—Valsartan—type 2 diabetes mellitus	3e-05	0.000144	CcSEcCtD
Escitalopram—Dry mouth—Ramipril—type 2 diabetes mellitus	3e-05	0.000144	CcSEcCtD
Escitalopram—Decreased appetite—Losartan—type 2 diabetes mellitus	2.99e-05	0.000143	CcSEcCtD
Escitalopram—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000143	CcSEcCtD
Escitalopram—Confusional state—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000142	CcSEcCtD
Escitalopram—Pruritus—Orlistat—type 2 diabetes mellitus	2.97e-05	0.000142	CcSEcCtD
Escitalopram—Fatigue—Losartan—type 2 diabetes mellitus	2.96e-05	0.000142	CcSEcCtD
Escitalopram—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000141	CcSEcCtD
Escitalopram—Oedema—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000141	CcSEcCtD
Escitalopram—Vomiting—Gliclazide—type 2 diabetes mellitus	2.94e-05	0.000141	CcSEcCtD
Escitalopram—Constipation—Losartan—type 2 diabetes mellitus	2.94e-05	0.000141	CcSEcCtD
Escitalopram—Pain—Losartan—type 2 diabetes mellitus	2.94e-05	0.000141	CcSEcCtD
Escitalopram—Rash—Gliclazide—type 2 diabetes mellitus	2.91e-05	0.00014	CcSEcCtD
Escitalopram—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.91e-05	0.00014	CcSEcCtD
Escitalopram—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.91e-05	0.000139	CcSEcCtD
Escitalopram—Urticaria—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.000139	CcSEcCtD
Escitalopram—Shock—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000139	CcSEcCtD
Escitalopram—Headache—Gliclazide—type 2 diabetes mellitus	2.9e-05	0.000139	CcSEcCtD
Escitalopram—Nervous system disorder—Ramipril—type 2 diabetes mellitus	2.89e-05	0.000139	CcSEcCtD
Escitalopram—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.88e-05	0.000138	CcSEcCtD
Escitalopram—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.88e-05	0.000138	CcSEcCtD
Escitalopram—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.88e-05	0.000138	CcSEcCtD
Escitalopram—Tachycardia—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000138	CcSEcCtD
Escitalopram—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.87e-05	0.000138	CcSEcCtD
Escitalopram—Skin disorder—Ramipril—type 2 diabetes mellitus	2.86e-05	0.000137	CcSEcCtD
Escitalopram—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000137	CcSEcCtD
Escitalopram—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.83e-05	0.000136	CcSEcCtD
Escitalopram—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.81e-05	0.000135	CcSEcCtD
Escitalopram—Dizziness—Valsartan—type 2 diabetes mellitus	2.81e-05	0.000135	CcSEcCtD
Escitalopram—Anorexia—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000135	CcSEcCtD
Escitalopram—Dizziness—Orlistat—type 2 diabetes mellitus	2.77e-05	0.000133	CcSEcCtD
Escitalopram—Asthenia—Metformin—type 2 diabetes mellitus	2.77e-05	0.000133	CcSEcCtD
Escitalopram—Hypotension—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000132	CcSEcCtD
Escitalopram—Nausea—Gliclazide—type 2 diabetes mellitus	2.75e-05	0.000132	CcSEcCtD
Escitalopram—Pruritus—Metformin—type 2 diabetes mellitus	2.74e-05	0.000131	CcSEcCtD
Escitalopram—Urticaria—Losartan—type 2 diabetes mellitus	2.73e-05	0.000131	CcSEcCtD
Escitalopram—Body temperature increased—Losartan—type 2 diabetes mellitus	2.71e-05	0.00013	CcSEcCtD
Escitalopram—Abdominal pain—Losartan—type 2 diabetes mellitus	2.71e-05	0.00013	CcSEcCtD
Escitalopram—Vomiting—Valsartan—type 2 diabetes mellitus	2.7e-05	0.00013	CcSEcCtD
Escitalopram—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.69e-05	0.000129	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000129	CcSEcCtD
Escitalopram—Rash—Valsartan—type 2 diabetes mellitus	2.68e-05	0.000128	CcSEcCtD
Escitalopram—Dermatitis—Valsartan—type 2 diabetes mellitus	2.68e-05	0.000128	CcSEcCtD
Escitalopram—Vomiting—Orlistat—type 2 diabetes mellitus	2.67e-05	0.000128	CcSEcCtD
Escitalopram—Insomnia—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000128	CcSEcCtD
Escitalopram—Headache—Valsartan—type 2 diabetes mellitus	2.66e-05	0.000128	CcSEcCtD
Escitalopram—Diarrhoea—Metformin—type 2 diabetes mellitus	2.65e-05	0.000127	CcSEcCtD
Escitalopram—Rash—Orlistat—type 2 diabetes mellitus	2.65e-05	0.000127	CcSEcCtD
Escitalopram—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000127	CcSEcCtD
Escitalopram—Dermatitis—Orlistat—type 2 diabetes mellitus	2.64e-05	0.000127	CcSEcCtD
Escitalopram—Headache—Orlistat—type 2 diabetes mellitus	2.63e-05	0.000126	CcSEcCtD
Escitalopram—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000126	CcSEcCtD
Escitalopram—Asthenia—Irbesartan—type 2 diabetes mellitus	2.62e-05	0.000126	CcSEcCtD
Escitalopram—Somnolence—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000126	CcSEcCtD
Escitalopram—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000124	CcSEcCtD
Escitalopram—Pruritus—Irbesartan—type 2 diabetes mellitus	2.58e-05	0.000124	CcSEcCtD
Escitalopram—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.56e-05	0.000123	CcSEcCtD
Escitalopram—Dizziness—Metformin—type 2 diabetes mellitus	2.56e-05	0.000123	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000122	CcSEcCtD
Escitalopram—Fatigue—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000122	CcSEcCtD
Escitalopram—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.53e-05	0.000121	CcSEcCtD
Escitalopram—Nausea—Valsartan—type 2 diabetes mellitus	2.52e-05	0.000121	CcSEcCtD
Escitalopram—Constipation—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000121	CcSEcCtD
Escitalopram—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.5e-05	0.00012	CcSEcCtD
Escitalopram—Nausea—Orlistat—type 2 diabetes mellitus	2.49e-05	0.00012	CcSEcCtD
Escitalopram—Asthenia—Losartan—type 2 diabetes mellitus	2.46e-05	0.000118	CcSEcCtD
Escitalopram—Vomiting—Metformin—type 2 diabetes mellitus	2.46e-05	0.000118	CcSEcCtD
Escitalopram—Rash—Metformin—type 2 diabetes mellitus	2.44e-05	0.000117	CcSEcCtD
Escitalopram—Dermatitis—Metformin—type 2 diabetes mellitus	2.44e-05	0.000117	CcSEcCtD
Escitalopram—Pruritus—Losartan—type 2 diabetes mellitus	2.43e-05	0.000117	CcSEcCtD
Escitalopram—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.43e-05	0.000116	CcSEcCtD
Escitalopram—Headache—Metformin—type 2 diabetes mellitus	2.42e-05	0.000116	CcSEcCtD
Escitalopram—Dizziness—Irbesartan—type 2 diabetes mellitus	2.41e-05	0.000116	CcSEcCtD
Escitalopram—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000116	CcSEcCtD
Escitalopram—Diarrhoea—Losartan—type 2 diabetes mellitus	2.35e-05	0.000113	CcSEcCtD
Escitalopram—Urticaria—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000112	CcSEcCtD
Escitalopram—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000112	CcSEcCtD
Escitalopram—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000112	CcSEcCtD
Escitalopram—Vomiting—Irbesartan—type 2 diabetes mellitus	2.32e-05	0.000111	CcSEcCtD
Escitalopram—Rash—Irbesartan—type 2 diabetes mellitus	2.3e-05	0.00011	CcSEcCtD
Escitalopram—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.3e-05	0.00011	CcSEcCtD
Escitalopram—Nausea—Metformin—type 2 diabetes mellitus	2.3e-05	0.00011	CcSEcCtD
Escitalopram—Headache—Irbesartan—type 2 diabetes mellitus	2.29e-05	0.00011	CcSEcCtD
Escitalopram—Dizziness—Losartan—type 2 diabetes mellitus	2.27e-05	0.000109	CcSEcCtD
Escitalopram—Vomiting—Losartan—type 2 diabetes mellitus	2.18e-05	0.000105	CcSEcCtD
Escitalopram—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.17e-05	0.000104	CcSEcCtD
Escitalopram—Nausea—Irbesartan—type 2 diabetes mellitus	2.17e-05	0.000104	CcSEcCtD
Escitalopram—Rash—Losartan—type 2 diabetes mellitus	2.17e-05	0.000104	CcSEcCtD
Escitalopram—Dermatitis—Losartan—type 2 diabetes mellitus	2.16e-05	0.000104	CcSEcCtD
Escitalopram—Headache—Losartan—type 2 diabetes mellitus	2.15e-05	0.000103	CcSEcCtD
Escitalopram—Asthenia—Ramipril—type 2 diabetes mellitus	2.11e-05	0.000101	CcSEcCtD
Escitalopram—Pruritus—Ramipril—type 2 diabetes mellitus	2.08e-05	0.0001	CcSEcCtD
Escitalopram—Nausea—Losartan—type 2 diabetes mellitus	2.04e-05	9.79e-05	CcSEcCtD
Escitalopram—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.01e-05	9.67e-05	CcSEcCtD
Escitalopram—Dizziness—Ramipril—type 2 diabetes mellitus	1.95e-05	9.34e-05	CcSEcCtD
Escitalopram—Vomiting—Ramipril—type 2 diabetes mellitus	1.87e-05	8.98e-05	CcSEcCtD
Escitalopram—Rash—Ramipril—type 2 diabetes mellitus	1.86e-05	8.91e-05	CcSEcCtD
Escitalopram—Dermatitis—Ramipril—type 2 diabetes mellitus	1.86e-05	8.9e-05	CcSEcCtD
Escitalopram—Headache—Ramipril—type 2 diabetes mellitus	1.84e-05	8.85e-05	CcSEcCtD
Escitalopram—Nausea—Ramipril—type 2 diabetes mellitus	1.75e-05	8.39e-05	CcSEcCtD
Escitalopram—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.12e-06	7.36e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.11e-06	7.35e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.07e-06	7.3e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.05e-06	7.27e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	5e-06	7.19e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.99e-06	7.18e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.98e-06	7.16e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.97e-06	7.16e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.96e-06	7.14e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.95e-06	7.13e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.95e-06	7.12e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.94e-06	7.1e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AGT—type 2 diabetes mellitus	4.93e-06	7.09e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.92e-06	7.07e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.92e-06	7.07e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	4.9e-06	7.05e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.89e-06	7.03e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.87e-06	7.01e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.85e-06	6.97e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—LEP—type 2 diabetes mellitus	4.83e-06	6.95e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOE—type 2 diabetes mellitus	4.83e-06	6.95e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.8e-06	6.9e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.78e-06	6.88e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.78e-06	6.88e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.78e-06	6.88e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.78e-06	6.88e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.77e-06	6.87e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.77e-06	6.86e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.72e-06	6.79e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.72e-06	6.79e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.68e-06	6.74e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.67e-06	6.72e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.6e-06	6.62e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.6e-06	6.62e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.6e-06	6.61e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.59e-06	6.6e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.59e-06	6.6e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.55e-06	6.55e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.52e-06	6.51e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.52e-06	6.51e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.51e-06	6.5e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	4.5e-06	6.47e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	4.48e-06	6.45e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	4.41e-06	6.35e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.31e-06	6.2e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.29e-06	6.17e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.28e-06	6.15e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.27e-06	6.15e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.27e-06	6.15e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.26e-06	6.14e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.26e-06	6.13e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.26e-06	6.13e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.24e-06	6.1e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.24e-06	6.1e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.22e-06	6.07e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.21e-06	6.05e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.2e-06	6.04e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.2e-06	6.04e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	4.19e-06	6.03e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.19e-06	6.02e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.19e-06	6.02e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.19e-06	6.02e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.17e-06	6e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.17e-06	6e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	4.16e-06	5.99e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.14e-06	5.95e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	4.13e-06	5.94e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.12e-06	5.93e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.12e-06	5.93e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	4.11e-06	5.91e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	4.11e-06	5.91e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.06e-06	5.84e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.06e-06	5.84e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	4.04e-06	5.81e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.99e-06	5.74e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.99e-06	5.74e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.98e-06	5.73e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.97e-06	5.71e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.95e-06	5.68e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.93e-06	5.66e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.93e-06	5.65e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.9e-06	5.61e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.9e-06	5.61e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.9e-06	5.61e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.9e-06	5.61e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.88e-06	5.58e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.87e-06	5.57e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.86e-06	5.55e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.83e-06	5.51e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.82e-06	5.5e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.8e-06	5.47e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.8e-06	5.47e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.8e-06	5.47e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.79e-06	5.45e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.78e-06	5.44e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.78e-06	5.43e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.76e-06	5.41e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.73e-06	5.37e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.72e-06	5.36e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.72e-06	5.35e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.71e-06	5.34e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.67e-06	5.28e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.66e-06	5.27e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.66e-06	5.27e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.62e-06	5.21e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.62e-06	5.21e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.62e-06	5.21e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.61e-06	5.2e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	3.58e-06	5.14e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	3.56e-06	5.13e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.55e-06	5.1e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.52e-06	5.06e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	3.51e-06	5.05e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.51e-06	5.05e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.47e-06	5e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.47e-06	5e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.46e-06	4.98e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.46e-06	4.98e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.46e-06	4.97e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.45e-06	4.97e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.45e-06	4.96e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.44e-06	4.96e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.44e-06	4.95e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.43e-06	4.94e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.41e-06	4.91e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.41e-06	4.91e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.41e-06	4.91e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.41e-06	4.9e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	3.41e-06	4.9e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.39e-06	4.88e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.39e-06	4.88e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.38e-06	4.86e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.37e-06	4.85e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.35e-06	4.82e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.33e-06	4.79e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.32e-06	4.77e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.3e-06	4.75e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.28e-06	4.73e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.27e-06	4.71e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.25e-06	4.67e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.24e-06	4.67e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.23e-06	4.65e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.22e-06	4.64e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.2e-06	4.6e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.19e-06	4.6e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.14e-06	4.51e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.14e-06	4.51e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.13e-06	4.51e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.13e-06	4.5e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.13e-06	4.5e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.12e-06	4.49e-05	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.1e-06	4.46e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.08e-06	4.44e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.08e-06	4.44e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.08e-06	4.43e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.08e-06	4.43e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.07e-06	4.42e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.05e-06	4.39e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.03e-06	4.37e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.98e-06	4.29e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.97e-06	4.28e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.96e-06	4.25e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.96e-06	4.25e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.95e-06	4.25e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.94e-06	4.23e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.94e-06	4.23e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.9e-06	4.18e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.9e-06	4.17e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.87e-06	4.13e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.82e-06	4.05e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.82e-06	4.05e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.76e-06	3.97e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.69e-06	3.87e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.68e-06	3.85e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	2.68e-06	3.85e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.66e-06	3.83e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.65e-06	3.82e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.64e-06	3.81e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.64e-06	3.79e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.64e-06	3.79e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.61e-06	3.76e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.61e-06	3.75e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.6e-06	3.73e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.59e-06	3.73e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.55e-06	3.67e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.55e-06	3.67e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.54e-06	3.66e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.54e-06	3.65e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.53e-06	3.64e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.52e-06	3.62e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.51e-06	3.61e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.5e-06	3.6e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.49e-06	3.58e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.48e-06	3.57e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.47e-06	3.55e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.44e-06	3.51e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.44e-06	3.51e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.43e-06	3.5e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.43e-06	3.5e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.42e-06	3.49e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.42e-06	3.49e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.39e-06	3.45e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.39e-06	3.44e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.36e-06	3.4e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.35e-06	3.38e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.33e-06	3.35e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.32e-06	3.34e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.32e-06	3.34e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.31e-06	3.33e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.28e-06	3.27e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.27e-06	3.27e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.26e-06	3.26e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.26e-06	3.25e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.25e-06	3.24e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.23e-06	3.21e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.23e-06	3.21e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.22e-06	3.19e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.22e-06	3.19e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.2e-06	3.17e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.18e-06	3.13e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.09e-06	3.01e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.07e-06	2.98e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.07e-06	2.97e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.05e-06	2.95e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.04e-06	2.93e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.03e-06	2.93e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.03e-06	2.93e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.03e-06	2.92e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.99e-06	2.87e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.98e-06	2.86e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.95e-06	2.81e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.94e-06	2.8e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.92e-06	2.77e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.8e-06	2.59e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.69e-06	2.44e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.66e-06	2.39e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.66e-06	2.39e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.56e-06	2.25e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.56e-06	2.24e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.53e-06	2.21e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.52e-06	2.19e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.46e-06	2.1e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.46e-06	2.1e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.44e-06	2.07e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.44e-06	2.07e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.41e-06	2.04e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-06	1.92e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	1.6e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-06	1.47e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.7e-07	9.63e-06	CbGpPWpGaD
